FDA
approval
· 2008-08-01
FDA Approved: CLEVIPREX — Original Application (Fresenius Kabi Austria GmbH)
Summary
FDA approved CLEVIPREX (clevidipine) from Fresenius Kabi Austria GmbH in an Original Application (NDA022156) for short-term intravenous management of acute hype…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CLEVIPREX (CLEVIDIPINE)